Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thymus Neoplasms × Everolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Breast Neoplasms 90 Carcinoma, Renal Cell 63 Neoplasm Metastasis 41 Neoplasms 34 Neuroendocrine Tumors 29 Kidney Neoplasms 24 Recurrence 16 Prostatic Neoplasms 16 Carcinoma, Non-Small-Cell Lung 16 Tuberous Sclerosis 15 Head and Neck Neoplasms 14 Triple Negative Breast Neoplasms 13 Lymphoma, Mantle-Cell 13 Lymphoma 12 Hodgkin Disease 12 Glioblastoma 12 Colorectal Neoplasms 12 Brain Neoplasms 12 Sarcoma 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Pancreatic Neoplasms 11 Lymphoma, Large B-Cell, Diffuse 11 Leukemia, Lymphocytic, Chronic, B-Cell 11 Carcinoma, Hepatocellular 11 Carcinoma, Neuroendocrine 10 Waldenstrom Macroglobulinemia 9 Stomach Neoplasms 9 Multiple Myeloma 9 Lymphoma, Follicular 9 Lung Neoplasms 9

Interventions

pembrolizumab 3 Proton Therapy 2 ribociclib 1 palbociclib 1 napabucasin 1 fludarabine 1 epacadostat 1 bosutinib 1 amrubicin 1 Sunitinib 1 Radiotherapy 1 Radiosurgery 1 Radiation 1 Plicamycin 1 Pemetrexed 1 Paclitaxel 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Fluorodeoxyglucose F18 1 FAPI-46 1 Everolimus 1 Erlotinib Hydrochloride 1 Drug Therapy 1 Cyclophosphamide 1 Cisplatin 1 Bevacizumab 1 Albumin-Bound Paclitaxel 1 177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05918302 2026-03-06

LEVEL

Grupo Espanol de Tumores Neuroendocrinos

Phase 3 Recruiting

Thymus Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡